way alter routine care. In pharmacogenetic implementation, this could be to avoid a drug or to change a drug dose, while genomic information could be used to intensify screening, undertake specific therapies, or to acquire long-term care insurance. Once a decision is made to implement genomic information in an EHR context, it must be coupled to clinical decision support to assist the provider by supplying background information and advice on genotype-specific actions to be taken: reduce a drug dose, change drugs, start more frequent cancer screening, etc. Systems that implement such approaches also need to develop methods to track and assess outcomes.
